Allarity Therapeutics (ALLR) Misses Q1 EPS by 17c

Allarity Therapeutics (NASDAQ: ALLR) reported Q1 EPS of ($0.17).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Chinese carmakers exploring Canada’s EV import quota, Joly says
• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%